HPV, tetanus vaccines causes deadly new autoimmune disease known as antiphospholipid syndrome
Ethan A. Huff, staff writer
(NaturalNews) One of the latest technologies being employed in the production of new vaccines involves the use of outer membrane vesicles (OMVs), a type of pathogenic bacteria that mimics the phospholipids naturally found in the human body, as customizable vaccine adjuvants. But vaccines that utilize this untested technology, which include vaccines for tetanus, human papillomavirus (HPV), and influenza, are now being linked to causing a potentially deadly autoimmune disease known as antiphospholipid syndrome (APS).
Several recent studies published in prominent medical journals have investigated the connection between APS, which belongs to a wider class of vaccine-induced health conditions known as autoimmune/inflammatory syndrome induced by adjuvants (ASIA), and vaccines, and found that OMVs are directly linked to triggering APS. Like the common vaccine adjuvant squalene, vaccine phospholipid materials, when injected into bodily tissue, can trigger an immune response that ends up causing the body to attack its own natural phospholipids.
As far as the tetanus vaccine is concerned, injections containing OMVs and recombinant (genetically-modified) DNA are being shown to cause blindness, cardiovascular disease, headaches and migraines, miscarriages, skin disorders, ulcers, necrosis, and neurological disorders. And as an increasing amount of vaccines are quietly converted to OMV-based adjuvant blends, the prevalence of APS is also expected to continue rising, as it already has been for quite some time.
"OMVs are even more precisely analogous to human tissue (than squalene), because they are not only lipids, they are phospholipids -- which are precisely what the body attacks in APS," explains Heidi Stevenson from Gaia Health about the growing prevalence of vaccine-induced APS. "Therefore, we can anticipate that there will be ever-more cases of APS as we see the approval of ever-more OMV-based vaccines, which are in the pipeline now."
Cervarix, the HPV vaccine rival to Merck & Co.'s Gardasil, contains OMVs, as do some flu vaccines -- and many more common vaccines are being reformulated with OMVs at this very moment. What this means is that we can expect an increasing number of vaccinated individuals to develop autoimmune symptoms as we move forward into the future. And such symptoms are likely to be systemic, as APS can target virtually all areas of the body.
"People with APS are suffering from phospholipid antibodies that are erroneously destroying parts of the eye, cardiovascular system, brain, nerves, skin, reproductive system -- in short, any part of the body," adds Stevenson about the horrific nature of this relatively new condition. "This self-destruction is induced by vaccine technologies."
Be sure to read Stevenson's full report on vaccine-induced APS here: http://gaia-health.com
Sources for this article include: